Glossary

Find Definition by Term and/or Language

Browse All Terms

Beginning With:
3 | 5 | A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z :: All
  • R Subgroup

    Also known as side chain. The group of atoms that differs among the 20 types of amino acid molecules and thus determines their diverse chemical properties; for example, the R subgroup on a glycine molecule is simply a hydrogen atom, on an alanine it is a methyl complex (a carbon and three hydrogens), and on glutamine it is a combination of carbon, oxygen, nitrogen, and hydrogen atoms.
  • R&D

    Research and Development
  • RA

    Regulatory Authority
  • Ra

    Arithmetic Average Roughness
  • RA

    Rinsed Area
  • RABS

  • RABS

    Restricted Access Barrier System
  • RAC

    Regulatory Affairs Committee (ISPE term)
  • RAC

    Recombinant DNA Advisory Committee (NIH Guidelines)
  • Racemate

    (ICH Q6A) A composite (solid, liquid, gaseous, or in solution) of equimolar quantities of two enantiomeric species. It is devoid of optical activity.
  • RACI

    Responsible, Accountable, Consulted, Informed
  • RACI Chart

    Matrix that defines who will do the work and be responsible for its completion (R), who will remain accountable for the completion of the work (A), who should be consulted as the work is being progressed (C), and who should be informed of the work upon completion (I).
  • RACT

    Reasonably Available Control Technology
  • RAD

    Rapid Application Development
  • Radiation Sterilization

    Sterilization using gamma radiation emitted from radioactive materials such as cobalt-60, or cesium 137. If proper dosage of nuclear radiation can be documented, sterility testing is not required.
  • Radioactive Drug Research Committee (RDRC)

    An institutional committee responsible for the use of radioactive drugs in human subjects for research purposes. Research involving human subjects that proposes to use radioactive drugs must meet various FDA requirements, including limitations on the pharmacological dose and the radiation dose. Furthermore, the exposure to radiation must be justified by the quality of the study and the importance of the information it seeks to obtain. The committee is also responsible for continuing review of the drug use to ensure that the research continues to comply with FDA requirements, including reporting obligations. The committee must include experts in nuclear medicine and the use of radioactive drugs, as well as other medical and scientific members. 21 CFR 36.1
  • Radioactive Isotope; Radioisotope

    An unstable isotope that emits ionizing radiation.
  • Radioactive Material

    A material or combination of materials that spontaneously emits ionizing radiation.
  • Radiofrequency Interference (RFI)

    High frequency electromagnetic waves that emanate from electronic devices such as chips and other electronic devices. An electromagnetic disturbance caused by such radiating and transmitting sources as electrostatic discharge (ESD), lightning, radar, radio and TV signals, and motors with brushes can induce unwanted voltages in electronic circuits, damage components and cause malfunctions.
  • Radiographic Examination (RT)

    A method of detecting imperfections in materials by passing X-ray or nuclear radiation through the material and presenting their image on a recording medium.
  • Radiography

    A nondestructive method of internal examination in which metal objects are exposed to a beam of X-ray or gamma radiation. Differences in thickness, density or absorption, caused by internal defects or inclusions, are apparent in the shadow image either on a fluorescent screen or on photographic film placed behind the object.
  • Radioimmunoassay (RIA)

    A highly sensitive method of detecting and measuring the concentration of biological compoundsIn vivo.
  • Radioimmunoassay (RIA)

    A sensitive method for detecting and measuring trace amounts of a biomolecule based on its ability to displace a radioactive version of itself from combination with its specific antibody.
  • Radiopharmaceuticals

    Drugs (compounds or materials) that may be labeled or tagged with a radioisotope. These materials are largely physiological or subpharmacological in action, and, in many cases, function much like materials found in the body. The principal risk associated with these materials is the consequent radiation exposure to the body or to specific organ systems when they are injected into the body.
  • Radioprotectant

    Substance that prevents or lessens the effects of radiation.